Researchers found that neural crest stem cells are uniquely capable of reprogramming, challenging current reprogramming ...

The field of engineered cell ... of cell therapy and immunology, we welcome articles addressing, but not limited to, the following themes: - Construction of CAR or other engineered T cell receptors - ...

cell therapy research and cell engineering are priorities to bolster research initiatives. In addition, supporting the research of young scientists with promising ideas is a key element of the ...

Medigene’s lead TCR-T program MDG1015 is a potential best-in-class, TCR-T therapy to treat multiple solid tumor indications. The End-to-End Platform technologies enable armoring and enhancing of these ...

Additionally, promising data from the ALLO-316 Phase 1 trial in renal cell carcinoma has led to a Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA. Financially, Allogene ended ...

UC San Francisco treated its first brain cancer patient with an experimental new CAR-T therapy discovered and manufactured at ...

Researchers from the Center for Regenerative Medicine (CReM) and the Department of Medicine at Boston Medical Center (BMC) ...

Cell and gene therapy companies are the beneficiaries of positive changes along the regulatory path that the U.S. FDA is paving for them, according to a panel of executives who spoke at the BioFuture ...